The company traded up yesterday 0.62 percent and hit $117.63 on 251,801 shares.
Here are six key notes, according to the report:
1. Argus updated the price from $166 to $135 yesterday.
2. Argus currently has a “buy” rating on Zimmer stock.
3. Jeffries Group upgraded Zimmer from a “hold” to a “buy” and raised their price from $119 to $131.
4. Deutsche Bank analyst raised their price target on Zimmer from $107 to $114 and gave the company a “hold” rating on Feb. 2.
5. Canaccord Genuity raised the price target from $130 to $150 on Jan. 30.
6. Robert W. Baird upgraded from “neutral” rating on the shares to “outperform” and raised the price target from $110 to $125.
More articles on orthopedic devices:
7 key trends in joint replacement customization
Amedica files FDA application for spinal implant spacers with porous silicon nitride center—6 things to know
Smith & Nephew launches new suture anchor
